However, newer medications target multiple metabolic hormones: GLP-1 drugs (single-hormone): semaglutide medications like Wegovy and Ozempic Dual-agonist drugs: tirzepatide medications like Mounjaro and Zepbound (target GLP-1 and GIP receptors) Triple-agonist drugs: retatrutide (targets GLP-1, GIP and glucagon receptors) Researchers believe stimulating multiple hormone pathways may produce stronger effects on appetite, metabolism and energy expenditure
This increased activity naturally leads to higher levels of oxidative stressa condition where the body has more free radicals than it can easily neutralize
As fat loss slows and body weight stabilizes, maintenance protein intake is typically slightly lower
Symptoms of Opioid Withdrawal Opioid withdrawal symptoms are generally divided into two stages: early and later
Why FDA Approval Matters for Weight Loss Injections Choosing FDA approved GLP-1 medications means the treatment has been evaluated for safety, effectiveness, and long-term use
We understand that starting a weight loss plan can be daunting, but with the expert care and personalized approach we offer at Lush Medspa, youll have all the support you need